Present status and treatment of paroxysmal supraventricular tachycardia

The therapeutic agents that have been described will successfully convert close to 100% of all episodes of PST in children. Digoxin is the most frequently used agent for treatment of acute PST and is highly effective and safe. Recently, cardioversion and beta-adrenergic blockade are being employed m...

Full description

Saved in:
Bibliographic Details
Published in:Pediatrics (Evanston) 1972-07, Vol.50 (1), p.127-130
Main Authors: Linde, L M, Turner, S W, Awa, S
Format: Article
Language:English
Subjects:
Child
Child, Preschool
Digoxin - therapeutic use
Electric Countershock
Electrocardiography
Humans
Infant
Lidocaine - therapeutic use
Pacemaker, Artificial
Posture
Procainamide - therapeutic use
Propranolol - therapeutic use
Tachycardia, Paroxysmal - diagnosis
Tachycardia, Paroxysmal - drug therapy
Tachycardia, Paroxysmal - etiology
Tachycardia, Paroxysmal - therapy
Valsalva Maneuver
Verapamil - therapeutic use
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The therapeutic agents that have been described will successfully convert close to 100% of all episodes of PST in children. Digoxin is the most frequently used agent for treatment of acute PST and is highly effective and safe. Recently, cardioversion and beta-adrenergic blockade are being employed more frequently, both with specific indications. Newer electrical means and new agents such as Verapamil are effective but the former are not yet widely used and the latter not yet authorized for use in the United States. Prophylaxis of recurrent episodes is usually successful with digoxin, with the addition or substitution of propranolol in certain conditions.
ISSN:0031-4005
1098-4275
DOI:10.1542/peds.50.1.127